top of page
Search

E* Chi'mes Pharmaceutical Inc. Presents NeuroAiD II in the Management of Mild Cognitive Impairment (MCI), Alzheimer’s Disease (AD), and Vascular Dementia (VD).

  • Mar 19
  • 0 min read

Updated: May 18



 
 
 

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page